Foldi J, Kahn A, Silber A, Qing T, et al. Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clin Cancer Res 2022;28:3720-3728.
PMID: 35903931